Skip to Main Content

Paper Details

Measurement of cetuximab and panitumumab-unbound serum EGFR extracellular domain using an assay based on slow off-rate modified aptamer (SOMAmer) reagents.
PLoS One
13
2013

Datasets

Release 1.2